The Effect of ShotBlocker in Reducing Pain Associated with Peripheral Intravenous Cannulation in School Age Children: A Randomized Controlled Trial (RCT)

College of Nursing, University of Baghdad0 个研究点目标入组 128 人开始时间: 待定最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•Consent to volunteer to participate in the study.
•Being between the ages of 6 and 12 years.
•Intravenous cannulation will be applied in right and left hand only.
•No difficulty in communication, including hearing, visual, speech, and language problems.
•Not receiving oral or parenteral analgesic treatment before administration.
•Not receiving chemotherapy treatment.

•Skin conditions such as burns, rashes, open wounds, abscess or boil, severe local infection or cellulitis at the intended insertion site.
•Peripheral vascular disease or compromised peripheral circulation at the intended insertion site (e. g. Peripheral neuropathy, diabetes, Peripheral artery disease, Raynaud's disease).
•Blood clotting disorders or increased risk of bleeding (e.g., hemophilia, thrombocytopenia).
•Anatomical abnormalities or restrictions that impede proper insertion or cause increased risk of complications.
•History of injections during the last 3 months.

发起方

College of Nursing, University of Baghdad